INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2011

Tour de France cyclists showed a 17% higher average longevity compared with the general population.

Researchers studied the longevity of 834 cyclists from France, Italy, and Belgium who rode the Tour de France between 1930 and 1964, collecting dates of birth and death as of December 31, 2007. Percentage of survivors at each age was compared with pooled data from the general population of those three countries for corresponding age cohorts. Average longevity was 17% higher in the cyclists than in the general population, and the age at which 50% died was 81.5 years in the cyclists versus 73.5 years in the general population.

Shows an association, not proof of cause and effect.

Study type
Retrospective cohort study
Who was studied
834 Tour de France cyclists from France (n=465), Italy (n=196), and Belgium (n=173) who rode between 1930 and 1964
What was measured
Average longevity and age at which 50% died compared with the general population

THE PAPER

Increased average longevity among the "Tour de France" cyclists.

Sanchis-Gomar F, Olaso-Gonzalez G, Corella D, Gomez-Cabrera MC, Vina J. Int J Sports Med, 2011.

PubMed 21618162 ↗DOI 10.1055/s-0031-1271711 ↗

Healthy aging & longevityOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.